|
Ronald B. Moss M.D. joined us as Vice President Clinical Development in June 2006. Prior to joining Vical Dr. Moss most recently was Vice-President of Medical Affairs at Telos Pharmaceuticals from 2004 to 2006. From 2003 to 2004 he served as a Senior Director of Worldwide Regulatory Affairs for Vaccines/Biologics in the Merck Research Laboratories Division of Merck and Co. Inc. where he worked on multiple vaccine programs. Dr. Moss joined The Immune Response Corp. in 1994 as Medical Director and advanced through positions of increasing responsibility concluding as Interim President and CEO in 2002. He had previously served for a year as Assistant Medical Director at Immunization Products Ltd. a joint venture between Rh�ne-Poulenc Rorer and Immune Response. Dr. Moss trained first as a Pediatrics Resident at SUNY and then as a Clinical Associate in Allergy and Clinical Immunology at the National Institutes of Health and is board certified in pediatrics and in allergy & immunology. He earned his M.D. degree at the Chicago Medical School and graduated Phi Beta Kappa with a bachelor's degree in 1982 from the State University of New York at Stony Brook. | 